Brief: Aslan Pharmaceuticals Announces Pricing Of ADS Offering
03/03/2021 05:46
March 3 (Reuters) - Aslan Pharmaceuticals Ltd 7A9y.F :
* ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING
OF
AMERICAN DEPOSITARY SHARES
* ASLAN PHARMACEUTICALS LTD - PRICES OFFERING OF AMERICAN
DEPOSITARY SHARES AT $4.00 PER ADS
Source text for Eikon: ID:nGNX70gYxr
Further company coverage: 7A9y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln